ANTX
AN2 Therapeutics·NASDAQ
--
--(--)
--
--(--)
3.79 / 10
Netural
Analyst sentiment is limited: one Buy rating with no strong track record, while fund flow scores 7.58/10, showing positive inflows in Small, Medium and Large caps but overall negative trend. Sentiment remains neutral.
Fund Flow Rating
Analyst RatingBuy
Wall Street Opinions
Buy
Strong Buy
0%
Buy
100%
Hold
0%
Sell
0%
Strong Sell
0%
Date2025-05-05
InstitutionJMP Securities
Times predicted1
Historical Win Rate0.0%
What is the market sentiment for ANTX?
- ANTX holds a Bearish analyst rating, with 100% of experts assigning a Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 3.79/10 (Netural).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
